-
1
-
-
0025978216
-
A phase i clinical, plasma, and cellular pharmacology study of gemcitabine
-
J.L. Abbruzzese, R. Grunewald, E.A. Weeks, D. Gravel, T. Adams, B. Nowak, S. Mineishi, P. Tarassoff, W. Satterlee, and M.N. Raber A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J. Clin. Oncol. 9 1991 491 498
-
(1991)
J. Clin. Oncol.
, vol.9
, pp. 491-498
-
-
Abbruzzese, J.L.1
Grunewald, R.2
Weeks, E.A.3
Gravel, D.4
Adams, T.5
Nowak, B.6
Mineishi, S.7
Tarassoff, P.8
Satterlee, W.9
Raber, M.N.10
-
2
-
-
47949094392
-
Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting
-
J.L. Arias, L.H. Reddy, and P. Couvreur Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting Langmuir 24 2008 7512 7519
-
(2008)
Langmuir
, vol.24
, pp. 7512-7519
-
-
Arias, J.L.1
Reddy, L.H.2
Couvreur, P.3
-
3
-
-
70350443227
-
Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine
-
J.L. Arias, L.H. Reddy, and P. Couvreur Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine J. Drug Target. 17 2009 586 598
-
(2009)
J. Drug Target.
, vol.17
, pp. 586-598
-
-
Arias, J.L.1
Reddy, L.H.2
Couvreur, P.3
-
4
-
-
77952211990
-
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
-
10.1007/s10637-009-9377-7
-
A.M. Bergman, A.D. Adema, J. Balzarini, S. Bruheim, I. Fichtner, P. Noordhuis, O. Fodstad, F. Myhren, M.L. Sandvold, H.R. Hendriks, and G.J. Peters Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models Invest New Drugs 2010 10.1007/s10637-009-9377-7
-
(2010)
Invest New Drugs
-
-
Bergman, A.M.1
Adema, A.D.2
Balzarini, J.3
Bruheim, S.4
Fichtner, I.5
Noordhuis, P.6
Fodstad, O.7
Myhren, F.8
Sandvold, M.L.9
Hendriks, H.R.10
Peters, G.J.11
-
5
-
-
0036462584
-
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
-
A.M. Bergman, H.M. Pinedo, and G.J. Peters Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) Drug Resist. Updat. 5 2002 19 33
-
(2002)
Drug Resist. Updat.
, vol.5
, pp. 19-33
-
-
Bergman, A.M.1
Pinedo, H.M.2
Peters, G.J.3
-
6
-
-
33847627626
-
Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs
-
P. Brusa, M.L. Immordino, F. Rocco, and L. Cattel Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs Anticancer Res. 27 2007 195 199
-
(2007)
Anticancer Res.
, vol.27
, pp. 195-199
-
-
Brusa, P.1
Immordino, M.L.2
Rocco, F.3
Cattel, L.4
-
7
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: A randomized trial
-
H.A. Burris 3rd, M.J. Moore, J. Andersen, M.R. Green, M.L. Rothenberg, M.R. Modiano, M.C. Cripps, R.K. Portenoy, A.M. Storniolo, P. Tarassoff, R. Nelson, F.A. Dorr, C.D. Stephens, and D.D. Von Hoff Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J. Clin. Oncol. 15 1997 2403 2413 (Pubitemid 27251144)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.6
, pp. 2403-2413
-
-
Burris III, H.A.1
Moore, M.J.2
Andersen, J.3
Green, M.R.4
Rothenberg, M.L.5
Modiano, M.R.6
Cripps, M.C.7
Portenoy, R.K.8
Storniolo, A.M.9
Tarassoff, P.10
Nelson, R.11
Dorr, F.A.12
Stephens, C.D.13
Von Hoff, D.D.14
-
8
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
-
(1984)
Adv. Enzyme Regul.
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
9
-
-
33645326198
-
Lecithin-based cationic nanoparticles as a potential DNA delivery system
-
Z. Cui, F. Qiu, and B.R. Sloat Lecithin-based cationic nanoparticles as a potential DNA delivery system Int. J. Pharm. 313 2006 206 213
-
(2006)
Int. J. Pharm.
, vol.313
, pp. 206-213
-
-
Cui, Z.1
Qiu, F.2
Sloat, B.R.3
-
10
-
-
0027275566
-
Physiological parameters in laboratory animals and humans
-
DOI 10.1023/A:1018943613122
-
B. Davies, and T. Morris Physiological parameters in laboratory animals and humans Pharm. Res. 10 1993 1093 1095 (Pubitemid 23211439)
-
(1993)
Pharmaceutical Research
, vol.10
, Issue.7
, pp. 1093-1095
-
-
Davies, B.1
Morris, T.2
-
11
-
-
79953054576
-
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
-
10.1016/j.addr.2010.04.009
-
J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev 2010 10.1016/j.addr.2010.04.009
-
(2010)
Adv. Drug Deliv. Rev
-
-
Fang, J.1
Nakamura, H.2
Maeda, H.3
-
12
-
-
34447518563
-
4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model
-
DOI 10.1080/10611860701453901, PII 779727421
-
4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model J. Drug Target. 15 2007 445 453 (Pubitemid 47073060)
-
(2007)
Journal of Drug Targeting
, vol.15
, Issue.6
, pp. 445-453
-
-
Gang, J.1
Park, S.-B.2
Hyung, W.3
Choi, E.H.4
Wen, J.5
Kim, H.-S.6
Shul, Y.-G.7
Haam, S.8
Song, S.Y.9
-
13
-
-
0142219312
-
Nucleoside Transporter Profiles in Human Pancreatic Cancer Cells: Role of hCNT1 in 2′,2′-Difluorodeoxycytidine-Induced Cytotoxicity
-
J. Garcia-Manteiga, M. Molina-Arcas, F.J. Casado, A. Mazo, and M. Pastor-Anglada Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2′,2′-difluorodeoxycytidine- induced cytotoxicity Clin. Cancer Res. 9 2003 5000 5008 (Pubitemid 37323307)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.13
, pp. 5000-5008
-
-
Garcia-Manteiga, J.1
Molina-Arcas, M.2
Casado, F.J.3
Mazo, A.4
Pastor-Anglada, M.5
-
14
-
-
0033615679
-
Selective protection of 2′,2′-difluorodeoxycytidine (Gemcitabine)
-
Z. Guo, and J.M. Gallo Selective protection of 2′,2′- difluorodeoxycytidine (Gemcitabine) J. Org. Chem. 64 1999 8319 8322
-
(1999)
J. Org. Chem.
, vol.64
, pp. 8319-8322
-
-
Guo, Z.1
Gallo, J.M.2
-
15
-
-
9644302465
-
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs
-
DOI 10.1016/j.jconrel.2004.09.001, PII S0168365904004341
-
M.L. Immordino, P. Brusa, F. Rocco, S. Arpicco, M. Ceruti, and L. Cattel Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs J. Control. Release 100 2004 331 346 (Pubitemid 39572916)
-
(2004)
Journal of Controlled Release
, vol.100
, Issue.3
, pp. 331-346
-
-
Immordino, M.L.1
Brusa, P.2
Rocco, F.3
Arpicco, S.4
Ceruti, M.5
Cattel, L.6
-
16
-
-
0035979950
-
Wetting and absorbency of nonionic surfactant solutions on cotton fabrics
-
DOI 10.1016/S0927-7757(01)00653-7, PII S0927775701006537
-
C. Kim, and Y.-L. Hsieh Wetting and absorbency of nonionic surfactant solutions on cotton fabrics Colloids Surf. A: Physicochem. Eng. Aspects 187-188 2001 385 397 (Pubitemid 32619174)
-
(2001)
Colloids and Surfaces A: Physicochemical and Engineering Aspects
, vol.187-188
, pp. 385-397
-
-
Kim, C.1
Hsieh, Y.-L.2
-
17
-
-
33746858503
-
Pancreatic cancer: From bench to 5-year survival
-
DOI 10.1097/01.mpa.0000229010.62538.f2, PII 0000667620060800000002
-
J. Kleeff, C. Michalski, H. Friess, and M.W. Buchler Pancreatic cancer: from bench to 5-year survival Pancreas 33 2006 111 118 (Pubitemid 44174558)
-
(2006)
Pancreas
, vol.33
, Issue.2
, pp. 111-118
-
-
Kleeff, J.1
Michalski, C.2
Friess, H.3
Buchler, M.W.4
-
18
-
-
45349095644
-
Tumor chemo-immunotherapy using gemcitabine and a synthetic dsRNA
-
U.M. Le, N. Yanasarn, C.V. Lohr, K.A. Fischer, and Z. Cui Tumor chemo-immunotherapy using gemcitabine and a synthetic dsRNA Cancer Biol. Ther. 7 2008 440 447 (Pubitemid 351847065)
-
(2008)
Cancer Biology and Therapy
, vol.7
, Issue.3
, pp. 440-447
-
-
Le, U.M.1
Yanasarn, N.2
Lohr, C.V.3
Fischer, K.A.4
Cui, Z.5
-
19
-
-
33750554489
-
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine
-
DOI 10.1097/01.cad.0000236303.97467.49, PII 0000181320061100000009
-
P. Pappas, D. Mavroudis, M. Nikolaidou, V. Georgoulias, and M. Marselos Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine Anticancer Drugs 17 2006 1185 1191 (Pubitemid 44673399)
-
(2006)
Anti-Cancer Drugs
, vol.17
, Issue.10
, pp. 1185-1191
-
-
Pappas, P.1
Mavroudis, D.2
Nikolaidou, M.3
Georgoulias, V.4
Marselos, M.5
-
20
-
-
75849117073
-
Novel targets for pancreatic cancer therapy
-
P.A. Philip Novel targets for pancreatic cancer therapy Surg. Oncol. Clin. N. Am. 19 2010 419 429
-
(2010)
Surg. Oncol. Clin. N. Am.
, vol.19
, pp. 419-429
-
-
Philip, P.A.1
-
21
-
-
22244438547
-
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft
-
DOI 10.1158/0008-5472.CAN-05-0602
-
G. Pratesi, G. Petrangolini, M. Tortoreto, A. Addis, S. Belluco, A. Rossini, S. Selleri, C. Rumio, S. Menard, and A. Balsari Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft Cancer Res. 65 2005 6388 6393 (Pubitemid 40994426)
-
(2005)
Cancer Research
, vol.65
, Issue.14
, pp. 6388-6393
-
-
Pratesi, G.1
Petrangolini, G.2
Tortoreto, M.3
Addis, A.4
Belluco, S.5
Rossini, A.6
Selleri, S.7
Rumio, C.8
Menard, S.9
Balsari, A.10
-
22
-
-
36148942471
-
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types
-
DOI 10.1016/j.jconrel.2007.08.018, PII S0168365907004245
-
L.H. Reddy, C. Dubernet, S.L. Mouelhi, P.E. Marque, D. Desmaele, and P. Couvreur A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types J. Control. Release 124 2007 20 27 (Pubitemid 350103730)
-
(2007)
Journal of Controlled Release
, vol.124
, Issue.1-2
, pp. 20-27
-
-
Reddy, L.H.1
Dubernet, C.2
Mouelhi, S.L.3
Marque, P.E.4
Desmaele, D.5
Couvreur, P.6
-
23
-
-
2942700264
-
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors
-
DOI 10.1200/JCO.2004.10.142
-
J.M. Reid, W. Qu, S.L. Safgren, M.M. Ames, M.D. Krailo, N.L. Seibel, J. Kuttesch, and J. Holcenberg Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors J. Clin. Oncol. 22 2004 2445 2451 (Pubitemid 41115403)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.12
, pp. 2445-2451
-
-
Reid, J.M.1
Qu, W.2
Safgren, S.L.3
Ames, M.M.4
Krailo, M.D.5
Seibel, N.L.6
Kuttesch, J.7
Holcenberg, J.8
-
24
-
-
70849127008
-
Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles
-
B.R. Sloat, M.A. Sandoval, A.M. Hau, Y. He, and Z. Cui Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles J. Control. Release 141 2010 93 100
-
(2010)
J. Control. Release
, vol.141
, pp. 93-100
-
-
Sloat, B.R.1
Sandoval, M.A.2
Hau, A.M.3
He, Y.4
Cui, Z.5
-
25
-
-
34648825412
-
Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules
-
DOI 10.1016/j.ijpharm.2007.06.006, PII S037851730700498X, New Trends in Drug Delivery Systems
-
B. Stella, S. Arpicco, F. Rocco, V. Marsaud, J.M. Renoir, L. Cattel, and P. Couvreur Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules Int. J. Pharm. 344 2007 71 77 (Pubitemid 47464827)
-
(2007)
International Journal of Pharmaceutics
, vol.344
, Issue.1-2
, pp. 71-77
-
-
Stella, B.1
Arpicco, S.2
Rocco, F.3
Marsaud, V.4
Renoir, J.-M.5
Cattel, L.6
Couvreur, P.7
-
26
-
-
33846410793
-
Predicting and controlling colloid suspension stability using electrophoretic mobility and particle size measurements
-
S. Sugrue Predicting and controlling colloid suspension stability using electrophoretic mobility and particle size measurements Am. Lab. 24 1992 64 71
-
(1992)
Am. Lab.
, vol.24
, pp. 64-71
-
-
Sugrue, S.1
-
28
-
-
61549106604
-
Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model
-
C.X. Wang, L.S. Huang, L.B. Hou, L. Jiang, Z.T. Yan, Y.L. Wang, and Z.L. Chen Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model Brain Res. 1261 2009 91 99
-
(2009)
Brain Res.
, vol.1261
, pp. 91-99
-
-
Wang, C.X.1
Huang, L.S.2
Hou, L.B.3
Jiang, L.4
Yan, Z.T.5
Wang, Y.L.6
Chen, Z.L.7
-
29
-
-
68649111125
-
Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel
-
N. Yanasarn, B.R. Sloat, and Z. Cui Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel Int. J. Pharm. 379 2009 174 180
-
(2009)
Int. J. Pharm.
, vol.379
, pp. 174-180
-
-
Yanasarn, N.1
Sloat, B.R.2
Cui, Z.3
-
30
-
-
77955519181
-
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
-
Y. Zhang, M. Huo, J. Zhou, and S. Xie PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Comput. Methods Programs Biomed. 99 2010 306 314
-
(2010)
Comput. Methods Programs Biomed.
, vol.99
, pp. 306-314
-
-
Zhang, Y.1
Huo, M.2
Zhou, J.3
Xie, S.4
|